null Option on Novocure
| NVCR Stock | USD 16.12 0.02 0.12% |
Novocure's latest option contracts expiring on September 19th 2025 are carrying combined implied volatility of 0.97 with a put-to-call open interest ratio of 0.11 over 43 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on September 19th 2025.
Open Interest Against September 19th 2025 Option Contracts
2025-09-19
The chart above shows Novocure's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Novocure's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Novocure's option, there is no secondary market available for investors to trade.
In The Money vs. Out of Money Option Contracts on Novocure
Analyzing Novocure's in-the-money options over time can help investors to take a profitable long position in Novocure regardless of its overall volatility. This is especially true when Novocure's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Novocure's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Novocure's stock while costing only a fraction of its price.
Novocure In The Money Call Balance
When Novocure's strike price is surpassing the current stock price, the option contract against Novocure stock is said to be in the money. When it comes to buying Novocure's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Novocure are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Novocure Current Options Market Mood
Novocure's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Novocure Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Novocure's options investors are not very successful. Novocure's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Novocure contract
Base on the Rule 16, the options market is currently suggesting that Novocure will have an average daily up or down price movement of about 0.0606% per day over the life of the 2025-09-19 option contract. With Novocure trading at USD 16.12, that is roughly USD 0.009773. If you think that the market is fully incorporating Novocure's daily price movement you should consider buying Novocure options at the current volatility level of 0.97%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Purchasing Novocure options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Novocure calls. Remember, the seller must deliver Novocure stock to the call owner when a call is exercised.
Novocure Option Chain
When Novocure's strike price is surpassing the current stock price, the option contract against Novocure stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Novocure's option chain is a display of a range of information that helps investors for ways to trade options on Novocure. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Novocure. It also shows strike prices and maturity days for a Novocure against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | NVCR250919C00040000 | 10 | 40.0 | 0.0 - 2.15 | 2.15 | Out |
Call | NVCR250919C00035000 | 46 | 35.0 | 0.0 - 2.0 | 0.05 | Out |
Call | NVCR250919C00034000 | 0 | 34.0 | 0.0 - 2.15 | 2.15 | |
Call | NVCR250919C00033000 | 29 | 33.0 | 0.0 - 2.15 | 2.15 | Out |
Call | NVCR250919C00032000 | 0 | 32.0 | 0.0 - 2.15 | 2.15 | |
Call | NVCR250919C00031000 | 62 | 31.0 | 0.0 - 2.15 | 0.17 | Out |
Call | NVCR250919C00030000 | 45 | 30.0 | 0.0 - 2.15 | 0.36 | Out |
Call | NVCR250919C00029000 | 4 | 29.0 | 0.0 - 2.15 | 2.15 | Out |
Call | NVCR250919C00028000 | 21 | 28.0 | 0.0 - 2.15 | 2.15 | Out |
Call | NVCR250919C00027000 | 7 | 27.0 | 0.0 - 2.15 | 2.15 | Out |
Call | NVCR250919C00026000 | 4 | 26.0 | 0.0 - 2.0 | 2.0 | Out |
Call | NVCR250919C00025000 | 65 | 25.0 | 0.0 - 0.35 | 0.15 | Out |
Call | NVCR250919C00024000 | 9 | 24.0 | 0.05 - 0.15 | 0.15 | Out |
Call | NVCR250919C00023000 | 46 | 23.0 | 0.0 - 0.15 | 0.15 | Out |
Call | NVCR250919C00022000 | 228 | 22.0 | 0.0 - 0.25 | 0.17 | Out |
Call | NVCR250919C00021000 | 707 | 21.0 | 0.0 - 0.55 | 0.7 | Out |
Call | NVCR250919C00020000 | 394 | 20.0 | 0.0 - 0.45 | 0.43 | Out |
Call | NVCR250919C00019000 | 80 | 19.0 | 0.0 - 0.7 | 1.42 | Out |
Call | NVCR250919C00018000 | 618 | 18.0 | 0.0 - 0.9 | 0.85 | Out |
Call | NVCR250919C00017000 | 101 | 17.0 | 0.0 - 1.3 | 1.17 | Out |
Call | NVCR250919C00016000 | 19 | 16.0 | 1.35 - 1.7 | 1.5 | In |
Call | NVCR250919C00015000 | 8 | 15.0 | 2.0 - 2.2 | 2.08 | In |
Put | NVCR250919P00040000 | 0 | 40.0 | 22.0 - 25.8 | 22.0 | In |
Put | NVCR250919P00035000 | 0 | 35.0 | 17.8 - 20.8 | 17.8 | In |
Put | NVCR250919P00034000 | 0 | 34.0 | 16.7 - 19.8 | 16.7 | In |
Put | NVCR250919P00033000 | 0 | 33.0 | 15.7 - 19.0 | 15.7 | In |
Put | NVCR250919P00032000 | 0 | 32.0 | 14.8 - 17.3 | 14.8 | In |
Put | NVCR250919P00031000 | 0 | 31.0 | 13.8 - 16.8 | 13.8 | In |
Put | NVCR250919P00030000 | 0 | 30.0 | 12.3 - 16.0 | 12.3 | In |
Put | NVCR250919P00029000 | 0 | 29.0 | 11.1 - 15.0 | 11.1 | In |
Put | NVCR250919P00028000 | 0 | 28.0 | 10.1 - 14.0 | 10.1 | In |
Put | NVCR250919P00027000 | 0 | 27.0 | 9.6 - 12.3 | 9.6 | In |
Put | NVCR250919P00025000 | 75 | 25.0 | 8.3 - 9.0 | 8.3 | In |
Put | NVCR250919P00022000 | 1 | 22.0 | 5.2 - 7.5 | 5.2 | In |
Put | NVCR250919P00020000 | 2 | 20.0 | 3.4 - 5.7 | 3.4 | In |
Put | NVCR250919P00019000 | 3 | 19.0 | 2.65 - 5.1 | 2.65 | In |
Put | NVCR250919P00018000 | 10 | 18.0 | 2.3 - 2.65 | 1.85 | In |
Put | NVCR250919P00017000 | 120 | 17.0 | 1.65 - 2.05 | 1.75 | In |
Put | NVCR250919P00016000 | 43 | 16.0 | 0.0 - 3.4 | 1.12 | Out |
Put | NVCR250919P00015000 | 4 | 15.0 | 0.0 - 0.95 | 0.6 | Out |
Put | NVCR250919P00014000 | 1 | 14.0 | 0.3 - 0.5 | 0.35 | Out |
Put | NVCR250919P00013000 | 4 | 13.0 | 0.0 - 2.2 | 2.2 | Out |
Put | NVCR250919P00011000 | 1 | 11.0 | 0.0 - 2.2 | 2.2 | Out |
Novocure Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Novocure Market Cap Over Time
Market Cap |
| Timeline |
Novocure Total Stockholder Equity
Total Stockholder Equity |
|
Novocure Corporate Management
| Piet MD | Head VP | Profile | |
| Barak BenArye | General Counsel | Profile | |
| William Burke | Chief Officer | Profile | |
| Frank Leonard | Executive Oncology | Profile | |
| Christoph Brackmann | Chief Officer | Profile | |
| Uri MD | Chief Officer | Profile |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.